Global Markets Direct's, 'Febrile Neutropenia - Pipeline Review, H2
2012', provides an overview of the Febrile Neutropenia therapeutic
pipeline. This report provides information on the therapeutic
development for Febrile Neutropenia, complete with latest updates, and
special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Febrile
Neutropenia.

Scope

- A snapshot of the global therapeutic scenario for Febrile Neutropenia.

- A review of the Febrile Neutropenia products under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging
from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and
combined therapeutics.

- Coverage of the Febrile Neutropenia pipeline on the basis of route of
administration and molecule type.

- Profiles of late-stage pipeline products featuring sections on product
description, mechanism of action and research & development progress.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics
under development for Febrile Neutropenia.